Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Following the announcement by the MoEUCC, substances manufactured or imported into Turkey in quantities of at least one tonne per year must be subject to temporary or permanent registration with the KKS by 30 September 2026 at the latest.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
Learn about the exclusion and substitution criteria for active substances in biocidal products under the Biocidal Products Regulation. Discover how stakeholders can contribute to the decision-making process and the importance of public consultations.
Spanish authorities require compliance with new criteria for hydroalcoholic products marketed as cosmetics by June 30th. Prohibited claims and labeling elements must be removed. Learn more about the European Commission's recommendations and how to ensure compliance.
UK companies must appoint an EU-based Food Business Operator to market food supplements in Europe. Notification and labeling changes are required due to Brexit, affecting mutual recognition and customs checks. Compliance with EU regulations is essential for market access.
Following Brexit, 2,900 UK REACH registrations face revocation due to non-transfer to EU entities, impacting market access for some substances. Companies can register as importers or appoint an Only Representative. A trade deal limits data use for UK REACH.
The General Directorate for Competition Policy, Consumer Affairs and Fraud Control (DGCCRF) is the French organization in charge of controlling institutions' compliance with European chemical regulations such as REACH and CLP. The last reports of the DGCCRF show striking results on the number of industries that are not yet compliant with those chemical regulations. Discover the main results of these reports and the measures taken by the DGCCRF in the following article!
Learn about the risks of non-compliance with the new medical devices regulation in Europe, including financial losses, damage to brand image, and sanctions by Member States. Understand evolving obligations and how to ensure compliance to avoid these risks.
